Kusumoto K, Bessho K, Fujimura K, Konishi Y, Ogawa Y, Iizuka T
Department of Plastic and Reconstructive Surgery, Kansai Medical University, Osaka, Japan.
J Craniomaxillofac Surg. 1996 Dec;24(6):360-5. doi: 10.1016/s1010-5182(96)80037-0.
A combination of recombinant human bone morphogenetic protein-2 (rhBMP-2), atelopeptide Type I collagen (CL) as a carrier and porous hydroxyapatite (pHAP) was implanted in a calf muscle pouch of the rat. Three rhBMP-2-implanted groups (2, 10 and 50 micrograms; each n = 5) and the control group (n = 5), in which only CL and pHAP were implanted, were established. Three weeks later, the implants were examined.
将重组人骨形态发生蛋白-2(rhBMP-2)、作为载体的I型脱端肽胶原蛋白(CL)和多孔羟基磷灰石(pHAP)的组合植入大鼠的小腿肌肉袋中。设立了三个植入rhBMP-2的组(2、10和50微克;每组n = 5)和对照组(n = 5),对照组仅植入CL和pHAP。三周后,对植入物进行检查。